Scarica l'app Stockscreener
177.65
1.46%
2.56
Pre-mercato:
177.01
-0.64
-0.36%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché ILMN Giù?
Forum
Previsione
Frazionamento azionario
Illumina Inc Borsa (ILMN) Ultime notizie
Insider Sell: Scott Davies Sells Shares of Illumina Inc (ILMN) - GuruFocus
Form 4 Illumina Inc For: 25 June By Investing.com - Investing.com Nigeria
Illumina chief legal officer sells $110,700 in company stock By Investing.com - Investing.com Nigeria
Illumina (NASDAQ: ILMN) legal chief sells 615 shares in open-market trade - Stock Titan
Form 144 ILLUMINA For: 25 June By Investing.com - Investing.com Nigeria
Illumina Inc. stock outperforms competitors on strong trading day - MarketWatch
Form 144 Illumina For: 25 June By Investing.com - Investing.com Canada
Illumina (NASDAQ: ILMN) affiliate files Form 144 reporting 98,400-share 10b5-1 sale - Stock Titan
Frances Arnold sells Illumina shares (ILMN) in multiple May–June 2026 trades - Stock Titan
Illumina welcomes Eli Lilly executive, shares react to Barclays target lift - Ad-hoc-news.de
Illumina Inc (ILMN) Stock Up 6.1% but GF Value Says Overvalued -- GF Score: 76/100 - GuruFocus
Why Illumina (ILMN) Stock Is Trading Up Today - Yahoo Finance
Chasing challenges & transforming global health - Illumina
Illumina Jumps 7.7% Amid Sector-Wide Rally - AlphaStreet
Illumina stock hits 52-week high at 177.76 USD - Investing.com
Illumina (ILMN) Stock After 80% One-Year Rebound Is The Price Now Justified - Yahoo Finance
How Investors May Respond To Illumina (ILMN) Adding Eli Lilly R&D Chief To Its Board - simplywall.st
Form 4 Illumina Inc For: 23 June By Investing.com - Investing.com South Africa
(ILMN) Movement as an Input in Quant Signal Sets - Stock Traders Daily
Adding Eli Lilly’s R&D Chief to the Board Might Change The Case For Investing In Illumina (ILMN) - Yahoo Finance
Illumina (ILMN) director Daniel Skovronsky receives 1,674-share RSU grant - Stock Titan
Illumina (ILMN) director Daniel Skovronsky files initial insider Form 3 - Stock Titan
Form 8K Illumina Inc For: 23 June By Investing.com - Investing.com Australia
Illumina, Inc. Announces Appointment of Daniel M. Skovronsky to Board of Directors, Effective June 16, 2026 - marketscreener.com
Illumina adds Eli Lilly executive to board of directors - Investing.com
Daniel M. Skovronsky, MD, PhD, appointed to Illumina's Board of Directors - Finviz
Illumina adds Daniel M. Skovronsky to its Board - TradingView
Illumina (NASDAQ: ILMN) appoints Eli Lilly R&D leader to its board - Stock Titan
Illumina adjusts analyst expectations, shares trade on rich valuation - AD HOC NEWS
The DRAGEN v4.3 from Illumina Inc.new pipelines push clinical sequencing speed - Ad-hoc-news.de
IQM Quantum Computers Appoints Former Illumina VP Craig Ciesla as CTO Ahead of Nasdaq Listing Through Merger with RAAQ – Minichart - Minichart
Illumina, Inc. (ILMN) Stock Analysis: Navigating Growth in Genomic Innovation with a 4.8% Revenue Surge - DirectorsTalk Interviews
IQM nomme Craig Ciesla, ancien vice-président d’Illumina, au poste de directeur technique ; Inés de Vega devient directrice scientifique - Eagle-Tribune
Ovarian Cancer Diagnostics Market Size to Reach USD 8.08 Billion by 2035 | SNS Insider - GlobeNewswire Inc.
Why Illumina’s NovaSeq X Plus is quietly reshaping high-throughput genomics - AD HOC NEWS
IQM Appoints Craig Ciesla, Former Illumina VP, as CTO; Inés de Vega Becomes Chief Scientist - Business Wire
Video: Professor Emma Baple on bringing whole-genome sequencing into clinical research - Illumina
Illumina Inc (ILMN) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Illumina StockCasdin Capital and Gotham build positions as consensus stays cautious - Ad-hoc-news.de
Illumina Inc (ILMN) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Illumina Inc (ILMN) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Illumina Inc (ILMN) Shares Fall 3.2% -- GF Value Says Still Over - GuruFocus
Illumina Inc (ILMN) Institutional Confidence - TradingKey
Illumina Inc (ILMN) Valuation: PE, PB & Fair Value Analysis - TradingKey
Illumina Inc (ILMN) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Illumina Inc (ILMN) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Illumina Inc (ILMN) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Illumina Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
DRAGEN™ v4.5 | Push-Button Oncology Research Pipelines: FASTQ In, Report Out - Illumina
Illumina Connected Analytics brings clinical-grade genomics to the cloud for hospitals and labs - AD HOC NEWS
Illumina Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Illumina Inc. Stock (US4523271090): Quarterly earnings and strategic reset in focus - AD HOC NEWS
New spatial twist, Illumina StrataMap Spatial Solution targets multi-omics labs - AD HOC NEWS
Is Illumina Inc (ILMN) Overvalued After 3.7% Rally? GF Value Say - GuruFocus
Illumina Inc. Stock (US4523271090): Analyst sentiment leans bullish after strong 12-month rebound - AD HOC NEWS
Illumina, Inc. (ILMN): Investor Outlook On A Genomic Pioneer With A 33.82% ROE - DirectorsTalk Interviews
What is proteomics? A simple guide to understanding measuring proteins at scale - Illumina
Illumina raised to overweight at JP Morgan after customer survey - MSN
Illumina Inc. Stock (US4523271090): shares steady as investors await next earnings catalyst - AD HOC NEWS
Liquidity Mapping Around (ILMN) Price Events - Stock Traders Daily
Illumina Inc. stock underperforms Friday when compared to competitors - MarketWatch
3.34%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):